SMAD2 and Cognitive impairment: Increased TGF-β1 leads to elevated Smad2/3 phosphorylation resulting in the Smad2/3 then translocation into the nucleus, enhancing the activity of the transcription factor Sp1, which mediates synaptic and cognitive deficits.